For example, germline variants in BRCA2 and ATM may cause increased risk for lung cancer [13, 15–17] and sarcoma [18, 19], two tumor types in our study that revealed a significant number of tumor (and germline) variants in hereditary cancer risk genes not typically associated with these tumor types. This evidence concerns the gene BRCA2 and lung cancer.